Boston Scientific Corporation (BSX)
Why Boston Scientific (BSX) Outpaced the Stock Market Today
Boston Scientific (BSX) closed at $84.49 in the latest trading session, marking a +0.42% move from the prior day.
Here's Why You Should Add BSX Stock to Your Portfolio Now
Investors remain optimistic about Boston Scientific due to its geographical expansions and impressive MedSurg market share gain.
3 MedTech Stocks to Buy as Monetary Policy Eases
Here, we pick three MedTech stocks, VCYT, BSX and PAHC, which are anticipated to gain strongly in 2024 from the loosening of monetary policy.
BSX Stock Gains From FARAPULSE PFA's PMDA Approval in Japan
Boston Scientific achieves PMDA approval for its FARAPULSE PFA System in Japan. The company expects to launch the system in the country in the upcoming weeks.
Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors
Boston Scientific (BSX) closed at $83.08 in the latest trading session, marking a -0.5% move from the prior day.
Boston Scientific (BSX) Rises But Trails Market: What Investors Should Know
Boston Scientific (BSX) closed at $84 in the latest trading session, marking a +0.1% move from the prior day.
Is Boston Scientific (BSX) a Solid Growth Stock? 3 Reasons to Think "Yes"
Boston Scientific (BSX) possesses solid growth attributes, which could help it handily outperform the market.
Boston Scientific (BSX) Is Up 2.10% in One Week: What You Should Know
Does Boston Scientific (BSX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Wall Street Analysts Think Boston Scientific (BSX) Is a Good Investment: Is It?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Boston Scientific Corporation (BSX) Soars to 52-Week High, Time to Cash Out?
Boston Scientific (BSX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here's Why Boston Scientific (BSX) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
BSX Gets FDA Nod on INGEVITY+ Pacing Lead in the LBBA: Stock to Gain?
Boston Scientific received FDA approval on the expanded indication for INGEVITY+ Pacing Leads. Data demonstrated this lead to be safe and effective for LBBA pacing.
